Matches in Wikidata for { <http://www.wikidata.org/entity/Q66078234> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q66078234 description "assaig clínic" @default.
- Q66078234 description "clinical trial" @default.
- Q66078234 description "clinical trial" @default.
- Q66078234 description "clinical trial" @default.
- Q66078234 description "clinical trial" @default.
- Q66078234 description "ensaio clínico" @default.
- Q66078234 description "ensayo clínico" @default.
- Q66078234 description "ensayu clínicu" @default.
- Q66078234 description "essai clinique" @default.
- Q66078234 description "klinisch onderzoek" @default.
- Q66078234 description "клінічне випробування" @default.
- Q66078234 name "Marched Pair Study Conventional Doxorubicin" @default.
- Q66078234 name "Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy" @default.
- Q66078234 type Item @default.
- Q66078234 label "Marched Pair Study Conventional Doxorubicin" @default.
- Q66078234 label "Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy" @default.
- Q66078234 prefLabel "Marched Pair Study Conventional Doxorubicin" @default.
- Q66078234 prefLabel "Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy" @default.
- Q66078234 P1132 Q66078234-AE2BCF58-D77F-42E3-889E-6736578D1B1D @default.
- Q66078234 P1476 Q66078234-09899010-D5A4-45C3-AB9F-5E6501B1718C @default.
- Q66078234 P2899 Q66078234-E3F8499B-7D91-4CBE-8AA9-D8F6B22F7DC2 @default.
- Q66078234 P3098 Q66078234-14D2B338-8D42-4D46-9BF7-F6810C70857B @default.
- Q66078234 P31 Q66078234-FD4BECFA-52B0-4460-BEAD-35254B707C3C @default.
- Q66078234 P4135 Q66078234-D5F3FEE7-2294-4EEE-8132-63375717BEFC @default.
- Q66078234 P4844 Q66078234-47CF5814-B245-4EFD-A2BD-C8FEC654CC3F @default.
- Q66078234 P4844 Q66078234-6B1F9A40-6BFC-4221-A205-4D55A38A0924 @default.
- Q66078234 P4844 Q66078234-78C6FB95-999A-461B-8DD1-29E2B647C96F @default.
- Q66078234 P4844 Q66078234-CF8F867B-83AB-4898-98CC-D6EB4D7E41A6 @default.
- Q66078234 P4844 Q66078234-EB4A4F73-60E3-4041-9D0F-ABE93637FAD4 @default.
- Q66078234 P580 Q66078234-22C27D00-F536-478E-AE98-21AB2FF0114B @default.
- Q66078234 P582 Q66078234-E3E929D0-DC47-4BD4-BC49-F677FC2F6BD7 @default.
- Q66078234 P6099 Q66078234-6A1BD26B-0C3D-4078-BD00-471801FEC001 @default.
- Q66078234 P6153 Q66078234-12A9081E-B256-4EBA-9092-9FF413B47937 @default.
- Q66078234 P8363 Q66078234-F64202E3-02F5-417B-AC6F-14EAE63D70CC @default.
- Q66078234 P859 Q66078234-DA765F63-EF03-4FB6-A759-B58E6CCCC753 @default.
- Q66078234 P1132 "+160" @default.
- Q66078234 P1476 "Marched Pair Study of the Standard Chemotherapy 4doxorubicin Plus Cyclophosphamide(AC) 60 + 4 Docetaxel Protocol Versus 4 PLD C35+4 Docetaxel in Neoadjuvant Chemotherapy of Breast Cancer" @default.
- Q66078234 P2899 "+18" @default.
- Q66078234 P3098 "NCT02953184" @default.
- Q66078234 P31 Q30612 @default.
- Q66078234 P4135 "+70" @default.
- Q66078234 P4844 Q18936 @default.
- Q66078234 P4844 Q29004943 @default.
- Q66078234 P4844 Q3905585 @default.
- Q66078234 P4844 Q3930720 @default.
- Q66078234 P4844 Q408524 @default.
- Q66078234 P580 "2016-11-01T00:00:00Z" @default.
- Q66078234 P582 "2019-11-01T00:00:00Z" @default.
- Q66078234 P6099 Q42824440 @default.
- Q66078234 P6153 Q10917207 @default.
- Q66078234 P8363 Q78089383 @default.
- Q66078234 P859 Q1432030 @default.